Validation and Quality Assessment of the Kilimanjaro Cancer Registry.

dc.contributor.author

Zullig, Leah L

dc.contributor.author

Schroeder, Kristin

dc.contributor.author

Nyindo, Pilli

dc.contributor.author

Namwai, Theresia

dc.contributor.author

Silayo, Elvis

dc.contributor.author

Msomba, Angelah

dc.contributor.author

Munishi, Michael Oresto

dc.contributor.author

Karia, Francis

dc.contributor.author

Muiruri, Charles

dc.contributor.author

Bartlett, John

dc.contributor.author

Maro, Venance

dc.contributor.author

Zafar, S Yousuf

dc.coverage.spatial

United States

dc.date.accessioned

2017-08-01T05:52:38Z

dc.date.available

2017-08-01T05:52:38Z

dc.date.issued

2016-12

dc.description.abstract

PURPOSE: Global cancer burden has increasingly shifted to low- and middle-income countries and is particularly pronounced in Africa. There remains a lack of comprehensive cancer information as a result of limited cancer registry development. In Moshi, Tanzania, a regional cancer registry exists at Kilimanjaro Christian Medical Center. Data quality is unknown. Our objective was to evaluate the completeness and quality of the Kilimanjaro Cancer Registry (KCR). METHODS: In October 2015, we conducted a retrospective review of KCR by validating the internal consistency of registry records with medical and pathology records. We randomly sampled approximately 100 total registry cases. Four reviewers not associated with the KCR manually collected data elements from medical records and compared them with KCR data. RESULTS: All 100 reviewed registry cases had complete cancer site and morphology included in the registry. Six had a recorded stage. For the majority (n = 92), the basis of diagnosis was pathology. Pathology reports were found in the medical record for 40% of patients; for the remainder, these were stored separately in the pathology department. Of sampled registry cases, the KCR and medical records were 98% and 94% concordant for primary cancer site and morphology, respectively. For 28%, recorded diagnosis dates were within 14 days of what was found in the medical record, and for 32%, they were within 30 days. CONCLUSION: The KCR has a high level of concordance for classification and coding when data are retrieved for validation. This parameter is one of the most important for measuring data quality in a regional cancer registry.

dc.identifier

https://www.ncbi.nlm.nih.gov/pubmed/28717724

dc.identifier

002873

dc.identifier.issn

2378-9506

dc.identifier.uri

https://hdl.handle.net/10161/15102

dc.language

eng

dc.publisher

American Society of Clinical Oncology (ASCO)

dc.relation.ispartof

J Glob Oncol

dc.relation.isversionof

10.1200/JGO.2015.002873

dc.title

Validation and Quality Assessment of the Kilimanjaro Cancer Registry.

dc.type

Journal article

duke.contributor.orcid

Zullig, Leah L|0000-0002-6638-409X

duke.contributor.orcid

Schroeder, Kristin|0000-0002-6433-6174

duke.contributor.orcid

Muiruri, Charles|0000-0003-0213-0362

duke.contributor.orcid

Zafar, S Yousuf|0000-0002-9039-5258

pubs.author-url

https://www.ncbi.nlm.nih.gov/pubmed/28717724

pubs.begin-page

381

pubs.end-page

386

pubs.issue

6

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Pediatrics

pubs.organisational-group

Pediatrics, Hematology-Oncology

pubs.organisational-group

School of Medicine

pubs.publication-status

Published online

pubs.volume

2

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Validation and Quality Assessment of the Kilimanjaro Cancer Registry.pdf
Size:
526.94 KB
Format:
Adobe Portable Document Format
Description:
Accepted version